Program to help develop and propel HCV treatment for HIV/HCV co-infected patients using Peg IFN and Ribavirin through Thailand’s National Health Security Office (NHSO)

Project no.: HIV-NAT 202/HCV treatment

This study will assess the quality of life and side effects of treatment with Peg IFN and Ribavarin at 24 weeks versus 48 weeks in HIV/HCV co-infected patients.